Trends in Prevalence and Determinants of Potentially Inappropriate Prescribing in the United States: 2007 to 2012
Artículo

Open/ Download
Publication date
2016Metadata
Show full item record
Cómo citar
Jirón Aliste, Marcela
Cómo citar
Trends in Prevalence and Determinants of Potentially Inappropriate Prescribing in the United States: 2007 to 2012
Author
Abstract
ObjectivesTo estimate the prevalence and determinants of the use of potentially inappropriate medications (PIMs) in older U.S. adults using the 2012 Beers criteria.
DesignRetrospective cohort study in a random national sample of Medicare beneficiaries.
SettingFee-for-service Medicare beneficiaries from 2007 to 2012.
ParticipantsU.S. population aged 65 and older with Parts A, B, and D enrollment in at least 1month during a calendar year (N=38,250 individuals; 1,308,116 observations).
MeasurementsThe 2012 Beers criteria were used to estimate the prevalence of the use of PIMs in each calendar month and over a 12-month period using data on diagnoses or conditions present in the previous 12months. Generalized estimating equations were used to account for the dependence of multiple monthly observations of a single person when estimating 95% confidence intervals (CIs), and logistic regression was used to identify independent determinants of PIM use.
ResultsThe point prevalence of the use of PIMs decreased from 37.6% (95% CI=37.0-38.1) in 2007 to 34.2% (95% CI=33.6-34.7) in 2012, with a statistically significant 2% (95% CI=1-3%) decline per year assuming a linear trend. The 1-year period prevalence declined from 64.9% in 2007 to 56.6% in 2012. The strongest predictor of PIM use was the number of drugs dispensed. Individuals aged 70 and older and those seen by a geriatrician were less likely to receive a PIM.
ConclusionFrom 2007 to 2012, the prevalence of PIM use in older U.S. adults decreased according to the 2012 Beers criteria, although it remains high, still affecting one-third each month and more than half over 12months. The number of dispensed prescriptions could be used to target future interventions.
Patrocinador
Pharmacoepidemiology Gillings Innovation Lab for the Population-Based Evaluation of Drug Benefits and Harms in Older U.S. Adults
GIL 200811.0010
Center for Pharmacoepidemiology, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina (UNC)
CER Strategic Initiative, UNC Clinical Translational Science Award
UL1TR001111
Cecil G. Sheps Center for Health Services Research, UNC
UNC School of Medicine
MECESUP Chile
UCH0811
National Institute on Aging (NIA)
R01 AG023178
Indexation
Artículo de publicación ISI
Quote Item
JAGS 64:788–797, 2016
Collections
The following license files are associated with this item: